INTERNATIONAL PATENT: SHENZHEN TARGETRX, INC., 深圳市塔吉瑞生物医药有限公司 FILES APPLICATION FOR "EGFR-TARGETED PROTEOLYSIS TARGETING CHIMERA COMPOUNDS, COMPOSITION THEREOF AND USE THEREOF"

GENEVA, Feb. 2 -- SHENZHEN TARGETRX, INC. (Third Floor, Building A1 Kexing Science Park, No.15 of Keyuan Road, Yuehai Subdistrict, Nanshan DistrictShenzhen, Guangdong 518057), 深圳市塔吉瑞生物医药有限公司 (中国广东省深圳市南山区粤海街道科苑路15号科兴科学园A1栋3层) filed a patent application (PCT/CN2025/110050) for "EGFR-TARGETED PROTEOLYSIS TARGETING CHIMERA COMPOUNDS, COMPOSITION THEREOF AND USE THEREOF" on Jul 23, 2025. With publication no. WO/2026/021470, the details related to the patent application w...